The Opto and Microfluidics Laboratory establish synergies among novel nanostructures, optics, biology and electrokinetics to develop disruptive new technologies in sensors, diagnostics, drug delivery and biofilms, using cost- effective tools. Our research advances understanding of interfaces and surface physics. Current research includes a shear- enhanced biosensor that meets the “ASSURED” criteria set by the World Health Organization for point-of-care (POC) devices. The biosensor is being used to develop a POC test for cancer panels, such as breast cancer. This same device is being used for monoclonal antibody purification without post-modifications in order to preserve antibody functions. We are also developing a microfluidic organ-on-a-chip platform to study interactions between nanoparticles and the blood-brain barrier. In collaboration with researchers at Rensselaer Polytechnic Institute (RPI), we are developing water purification membrane technology in which membranes are coated with the latest semiconductors, including graphene, MOS (metal oxide semiconductors) and ReS2, a rhenium sulfide mineral. Our collaborators include researchers at NJIT, RPI and Hackensack Medical Center.